R2696 (Ramipril 5 mg)
Pill with imprint R2696 is Yellow, Capsule-shape and has been identified as Ramipril 5 mg. It is supplied by Actavis.
Ramipril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure; cardiovascular risk reduction (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R2696
Ramipril
- Imprint:
- R2696
- Strength:
- 5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis
- National Drug Code (NDC):
- 00228-2696
More about ramipril
- Ramipril Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 67 Reviews – Add your own review/rating
- Drug class: Angiotensin Converting Enzyme Inhibitors
Consumer resources
Other brands: Altace
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
